Evaluation of corneal epithelial wound healing after penetrating keratoplasty in patients receiving a new matrix therapy agent (regenerating agent)

Abstract

Objectives:

Complete epithelial wound healing is a milestone in early postoperative care after penetrating keratoplasty. The re-epithelialization rate after penetrating keratoplasty was measured in patients receiving a new matrix therapy agent (regenerating agent, Cacicol^®) that mimics heparan sulphates.

Methods:

This was a prospective, open-label, uncontrolled, single-centre observational study. A total of 33 consecutive patients (33 eyes) who underwent an 8.25-mm diameter penetrating keratoplasty were treated with regenerating agent eye drops: one drop in the operating theatre immediately after graft, then on alternate days. Patients were divided into those at low risk (13 patients) and high risk (20 patients) of delayed wound healing, and follow-up was performed by digital slit lamp with fluorescein-dye testing repeated daily at a fixed time. Dye area was measured using ImageJ freeware. The main endpoint was epithelial healing after regenerating agent therapy.

Results:

The mean ± standard deviation time to complete healing for all patients was 2.7 ± 1.1 (median: 3, range: 1–6) days. This was obtained on Day 1 for 15% of patients, Day 2 for 33%, Day 3 for 88%, Day 4 for 94% and Day 6 for 100%. There was no significant difference between low- and high-risk patients. The area of epithelial defect decreased by a mean ± standard deviation of 75% ± 22% between Day 1 and Day 2, corresponding to a mean ± standard deviation wound-healing rate of 11.5 ± 6.5 mm²/D. There were no systemic or local side effects related to regenerating agent.

Conclusion:

These preliminary data suggest that regenerating agent could be a useful, non-invasive therapeutic approach in postoperative management of penetrating keratoplasty with the potential to accelerate re-epithelialization.

Keywords

Cornea epithelial wound healing matrix therapy agent penetrating keratoplasty

Get full access to this article

View all access options for this article.

References

Borderie

Touzeau

Bourcier

, et al. Graft reepithelialization after penetrating keratoplasty using organ-cultured donor tissue. Ophthalmol 2006; 113(12): 2181–2186.

Nelson

Hodge

Bourne

WM.

In vitro comparison of Chen medium and Optisol-GS medium for human corneal storage. Cornea 2000; 19(6): 782–787.

Crewe

Armitage

WJ.

Integrity of epithelium and endothelium in organ-cultured human corneas. Invest Ophthalmol Vis Sci 2001; 42(8): 1757–1761.

Greenbaum

Hasany

Rootman

Optisol vs Dexsol as storage media for preservation of human corneal epithelium. Eye 2004; 18(5): 519–524.

Feizi

Javadi

MA.

Graft epithelial defects after deep anterior lamellar keratoplasty. Cornea 2014; 33(11): 1145–1148.

Lindstrom

Kaufman

Skelnik

, et al. Optisol corneal storage medium. Am J Ophthalmol 1992; 114(3): 345–356.

Meyer

Bobb

KC.

Corneal epithelium in penetrating keratoplasty. Am J Ophthalmol 1980; 90(2): 142–147.

Cheour

Nasri

Kamoun

, et al. Factors associated with graft reepithelialization after penetrating keratoplasty. J Fr Ophtalmol 2008; 31(8): 786–789.

Chen

Huang

, et al. The effect of topical autologous serum on graft re-epithelialization after penetrating keratoplasty. Am J Ophthalmol 2010; 150(3): 352–359.e2.

10.

Naor

Slomovic

Chipman

, et al. A randomized, double-masked clinical trial of Optisol-GS vs Chen medium for human corneal storage. Arch Ophthalmol 2002; 120(10): 1280–1285.

11.

Alcalde

Inigo-Portugues

Carreno

, et al. Effects of new biomimetic regenerating agents on corneal wound healing in an experimental model of post-surgical corneal ulcers. Arch Soc Esp Oftalmol 2015; 90(10): 467–474.

12.

Brignole-Baudouin

Warnet

Barritault

, et al. RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies. J Fr Ophtalmol 2013; 36(9): 740–747.

13.

Cejkova

Olmiere

Cejka

, et al. The healing of alkali-injured cornea is stimulated by a novel matrix regenerating agent (RGTA, CACICOL20): a biopolymer mimicking heparan sulfates reducing proteolytic, oxidative and nitrosative damage. Histol Histopathol 2014; 29(4): 457–478.

14.

Aifa

Gueudry

Portmann

, et al. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Invest Ophthalmol Vis Sci 2012; 53(13): 8181–8185.

15.

Bata

Witkowska

Wozniak

, et al. Effect of a matrix therapy agent on corneal epithelial healing after standard collagen cross-linking in patients with keratoconus: a randomized clinical trial. JAMA Ophthalmol 2016; 134(10): 1169–1176.

16.

Chappelet

Bernheim

Chiquet

, et al. Effect of a new matrix therapy agent in persistent epithelial defects after bacterial keratitis treated with topical fortified antibiotics. Cornea 2017; 36(9): 1061–1068.

17.

Chebbi

Kichenin

Amar

, et al. Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy. J Fr Ophtalmol 2008; 31(5): 465–471.

18.

De Monchy

Labbe

Pogorzalek

, et al. Management of herpes zoster neurotrophic ulcer using a new matrix therapy agent (RGTA): a case report. J Fr Ophtalmol 2012; 35(3): 187.e1–187.e6.

19.

Hovakimyan

Stachs

Celine

, et al. Matrix-based regenerating agent for corneal wound healing after collagen cross-linking. Cornea 2016; 35(12): 1638–1643.

20.

Kymionis

Liakopoulos

Grentzelos

, et al. Combined topical application of a regenerative agent with a bandage contact lens for the treatment of persistent epithelial defects. Cornea 2014; 33(8): 868–872.

21.

Kymionis

Liakopoulos

Grentzelos

, et al. Effect of the regenerative agent poly(carboxymethylglucose sulfate) on corneal wound healing after corneal cross-linking for keratoconus. Cornea 2015; 34(8): 928–931.

22.

Mateo

Abadia

Calvo

, et al. Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapy. J Ophthalmic Inflamm Infect 2015; 5: 18.

23.

Niederer

Perumal

Sherwin

, et al. Corneal innervation and cellular changes after corneal transplantation: an in vivo confocal microscopy study. Invest Ophthalmol Vis Sci 2007; 48(2): 621–626.

24.

Liu

Kao

WW.

Corneal epithelial wound healing. Prog Mol Biol Transl Sci 2015; 134: 61–71.

25.

ImageJ. Image processing and analysis in Java, https://imagej.nih.gov/ij/ (accessed 18 october 2018).

26.

Gain

Jullienne

, et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol 2016; 134(2): 167–173.

27.

Sugar

Gal

Beck

, et al. Baseline donor characteristics in the Cornea Donor Study. Cornea 2005; 24(4): 389–396.

28.

Ljubimov

Saghizadeh

Progress in corneal wound healing. Prog Retin Eye Res 2015; 49: 17–45.

29.

Reed

Mannis

Hills

, et al. Corneal epithelial healing after penetrating keratoplasty using topical Healon versus balanced salt solution. Ophthalmic Surg 1987; 18(7): 525–528.

30.

Scheer

Borderie

Touzeau

, et al. Effect of sodium hyaluronate administered at the end of penetrating keratoplasty on reepithelialization of the graft. J Fr Ophtalmol 1999; 22(8): 859–863.

31.

Fredj-Reygrobellet

Hristova

Ettaiche

, et al. CMDBS, functional analogue of heparin sulfate as a new class of corneal ulcer healing agents. Ophthalmic Res 1994; 26(6): 325–331.

32.

Tardieu

Gamby

Avramoglou

, et al. Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF. J Cell Physiol 1992; 150(1): 194–203.

33.

Coulson-Thomas

Chang

Yeh

, et al. Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing. Invest Ophthalmol Vis Sci 2015; 56(5): 3004–3014.

34.

Gumus

Guerra

de Melo Marques

, et al. A new matrix therapy agent for faster corneal healing and less ocular discomfort following epi-off accelerated corneal cross-linking in progressive keratoconus. J Refract Surg 2017; 33(3): 163–170.